Bradley Canino
Stock Analyst at Stifel
(1.91)
# 2,951
Out of 4,944 analysts
85
Total ratings
31.58%
Success rate
-4.81%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bradley Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | Maintains: Buy | $16 → $15 | $2.77 | +441.52% | 5 | Mar 7, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Hold | $3 → $1.5 | $0.66 | +127.07% | 8 | Mar 7, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $23 → $19 | $7.64 | +148.69% | 2 | Feb 28, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $27 → $23 | $3.42 | +572.51% | 5 | Feb 27, 2025 | |
| ARVN Arvinas | Maintains: Buy | $63 → $51 | $7.09 | +619.32% | 6 | Feb 12, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $70 → $115 | $24.96 | +360.74% | 2 | Dec 3, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $40 → $41 | $13.45 | +204.83% | 5 | Oct 14, 2024 | |
| KURA Kura Oncology | Downgrades: Hold | $26 → $19 | $6.49 | +192.76% | 6 | Oct 14, 2024 | |
| CELC Celcuity | Maintains: Buy | $39 → $42 | $52.37 | -19.80% | 4 | Oct 7, 2024 | |
| SMMT Summit Therapeutics | Maintains: Buy | $25 → $40 | $26.87 | +48.86% | 4 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $78.24 | +72.55% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $9.83 | +103.46% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.07 | +834.58% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $10 | $1.49 | +571.14% | 17 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $99 | $67.22 | +47.28% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $2.33 | +500.86% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $40.74 | +35.00% | 4 | Feb 23, 2024 |
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $2.77
Upside: +441.52%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3 → $1.5
Current: $0.66
Upside: +127.07%
Cullinan Therapeutics
Feb 28, 2025
Maintains: Buy
Price Target: $23 → $19
Current: $7.64
Upside: +148.69%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27 → $23
Current: $3.42
Upside: +572.51%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63 → $51
Current: $7.09
Upside: +619.32%
Janux Therapeutics
Dec 3, 2024
Maintains: Buy
Price Target: $70 → $115
Current: $24.96
Upside: +360.74%
Syndax Pharmaceuticals
Oct 14, 2024
Maintains: Buy
Price Target: $40 → $41
Current: $13.45
Upside: +204.83%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $6.49
Upside: +192.76%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39 → $42
Current: $52.37
Upside: -19.80%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25 → $40
Current: $26.87
Upside: +48.86%
Sep 16, 2024
Maintains: Buy
Price Target: $115 → $135
Current: $78.24
Upside: +72.55%
Sep 6, 2024
Initiates: Buy
Price Target: $20
Current: $9.83
Upside: +103.46%
Aug 8, 2024
Initiates: Buy
Price Target: $10
Current: $1.07
Upside: +834.58%
Jun 18, 2024
Maintains: Buy
Price Target: $32 → $10
Current: $1.49
Upside: +571.14%
Jun 17, 2024
Maintains: Buy
Price Target: $90 → $99
Current: $67.22
Upside: +47.28%
May 9, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $2.33
Upside: +500.86%
Feb 23, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $40.74
Upside: +35.00%